Fund Holdings — Velan Capital Investment Management LP

Total Portfolio Value
$99.94M
Total Bought
$21.27M
Total Sold
$22.66M
Net Transaction
-$1.39M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CIDARATHERAPEUTICSINC0100,000+100,00004,8714.87%+4,871
ALUMISINC01,620,846+1,620,84604,8634.87%+4,863
ARVINASINC(ARVN)0500,000+500,00003,6803.68%+3,680
VERONAPHARMAPLC95,00095,00006,0328,9858.99%+2,954
REZOLUTEINC(RZLT)400,000750,000+350,0001,1603,3453.35%+2,185
JASPERTHERAPEUTICSINC(JSPR)1,433,8281,433,82806,1657,9587.96%+1,792
SUTROBIOPHARMAINC(STRO)1,030,0003,060,000+2,030,0006702,1852.19%+1,514
ZEVRATHERAPEUTICSINC(ZVRA)665,000715,000+50,0004,9816,2996.30%+1,318
VIRIDIANTHERAPEUTICSINC(VRDN)086,500+86,50001,2091.21%+1,209
SCPHARMACEUTICALSINC917,668917,66802,4133,4963.50%+1,083
PERSPECTIVETHERAPEUTICSINC(CATX)500,000500,00001,0651,7201.72%+655
TELABIOINC(TELA)747,410747,41009121,4501.45%+538
UPSTREAMBIOINC(UPB)107,000107,00006551,1751.18%+520
PROTAGONISTTHERAPEUTICSINC03,700+3,70002040.20%+204
CYTOMXTHERAPEUTICSINC(CTMX)75,00075,0000481700.17%+123
NURIXTHERAPEUTICSINC(NRIX)010,000+10,00001140.11%+114
CORBUSPHARMACEUTICALSHLDGS(CRBP)59,00059,00003134070.41%+94
IMMIXBIOPHARMAINC(IMMX)025,000+25,0000520.05%+52
VYNETHERAPEUTICSINC(YARW)030,000+30,0000500.05%+50
PYXISONCOLOGYINC(PYXS)040,000+40,0000440.04%+44
VENTYXBIOSCIENCESINC40,00040,000046860.09%+40
LARIMARTHERAPEUTICSINC(LRMR)28,00033,000+5,00060950.10%+35
PROQRTHRAPEUTICSNV
SHS EURO
45,00045,000060920.09%+32
TERNSPHARMACEUTICALSINC17,00020,000+3,00047750.07%+28
OVIDTHERAPEUTICSINC(OVID)97,000160,000+63,00030530.05%+23
ERASCAINC(ERAS)50,00065,000+15,00069830.08%+14
DESIGNTHERAPEUTICSINC(DSGN)14,00020,000+6,00054670.07%+13
CONTEXTTHERAPEUTICSINC(CNTX)90,000100,000+10,00055660.07%+10
GOSSAMERBIOINC(GOSS)75,00075,000083920.09%+10
ALECTORINC55,00055,000068770.08%+9
NEXTCUREINC25,00045,000+20,00012210.02%+9
4DMOLECULARTHERAPEUTICSIN12,00012,000039450.04%+6
PMVPHARMACEUTICALSINC(PMVP)35,00035,000038370.04%-1
ACLARISTHERAPEUTICSINC(ACRS)35,00032,700-2,30054460.05%-7
WAVELIFESCIENCESLTD(WVE)13,00015,000+2,000105980.10%-8
ELEVATION ONCOLOGY INC45,0000-45,000120—-12
KIORAPHARMACEUTICALSINC(KPRX)122,223122,22303683520.35%-16
KRONOS BIO INC35,0000-35,000290—-29
MINERALYSTHERAPEUTICSINC(MLYS)150,600174,600+24,0002,3922,3622.36%-29
TENAXTHERAPEUTICSINC(TENX)83,33383,33305464800.48%-66
REPLIMUNEGROUPINC(REPL)182,083183,083+1,0001,7751,7011.70%-74
AVALOTHERAPEUTICSINC(AVTX)111,972154,972+43,0008977730.77%-124
REGULUS THERAPEUTICS INC80,0000-80,0001400—-140
ELEDONPHARMACEUTICALSINC(ELDN)323,973338,973+15,0001,0989190.92%-180
EDESABIOTECHINC(EDSA)687,500687,50001,6781,3961.40%-282
INSPIREMDINC(NSPR)904,029904,02902,4322,0522.05%-380
PROTARATHERAPEUTICSINC(TARA)1,667,8002,139,000+471,2007,1056,4816.48%-624
TOURMALINEBIOINC455,412393,889-61,5236,9276,2986.30%-629
PRAXISPRECISIONMEDICINESI(PRAX)185,000149,334-35,6667,0066,2796.28%-726
HERONTHERAPEUTICSINC(HRTX)6,986,7446,986,744015,37114,46314.47%-908
GERONCORP(GERN)655,00070,000-585,0001,041990.10%-943
IMMUNOME INC(IMNM)153,5000-153,5001,0330—-1,033
INSTIL BIO INC(TIL)69,0000-69,0001,1980—-1,198
LIQUIDIACORPORATION(LQDA)300,000239,260-60,7404,4252,9812.98%-1,444
SPRINGWORKS THERAPEUTICS INC185,5200-185,5208,1870—-8,187
ACELYRIN INC3,366,9450-3,366,9458,3160—-8,316
Page 1 of 1
Velan Capital Investment Management LP — 13F Holdings — Q2 2025 | TickerTrail